Courtney Carter
Family · Royse City, TXNPI 1265982383
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,220 and has fallen 89.7% since, to $126 in 2025.
Across 182 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$476
- Lilly USA, LLC$308
- Abbott$298
- Novo Nordisk$279
- Merck$205
- Amarin Pharma, Inc.$183
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,96697%
- Education$943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $476 |
| Lilly USA, LLC | 25 | $308 |
| Abbott | 15 | $298 |
| Novo Nordisk | 18 | $279 |
| Merck | 13 | $205 |
| Amarin Pharma, Inc. | 10 | $183 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $144 |
| AstraZeneca | 7 | $107 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $100 |
| Biohaven Pharmaceuticals, Inc. | 4 | $97 |
| Astellas Pharma US Inc | 1 | $94 |
| GSK | 6 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Mayne Pharma Commercial LLC | 3 | $73 |
| Bayer | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| Ironwood Pharmaceuticals, Inc | 2 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Organon | 1 | $18 |
| Lupin Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Novartis | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Exeltis, USA Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$126
How this compares
$3,060 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Other family in Royse City
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.